The Greenrose Holding Co (STU:50U) Return-on-Tangible-Equity: 0.00% (As of Sep. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:50U The Greenrose Holding Co STU:50U
22 GF Score
Price €2.36
View Full Analysis

What is The Greenrose Holding Co Return-on-Tangible-Equity?

The Greenrose Holding Co STU:50U 22 Return-on-Tangible-Equity is 0.00% as of Sep. 2022. GuruFocus rates STU:50U with a GF Score™ of 22/100.

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. The Greenrose Holding Co's annualized net income for the quarter that ended in Sep. 2022 was €-145.58 Mil. The Greenrose Holding Co's average shareholder tangible equity for the quarter that ended in Sep. 2022 was €-117.91 Mil. Therefore, The Greenrose Holding Co's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2022 was N/A%.

The historical rank and industry rank for The Greenrose Holding Co's Return-on-Tangible-Equity or its related term are showing as below:

STU:50U's Return-on-Tangible-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.95
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

The Greenrose Holding Co  (STU:50U) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


The Greenrose Holding Co Return-on-Tangible-Equity Related Terms


The Greenrose Holding Co Return-on-Tangible-Equity Historical Data

* Premium members only.

The historical data trend for The Greenrose Holding Co's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Greenrose Holding Co Return-on-Tangible-Equity Chart

The Greenrose Holding Co Annual Data
Trend Dec19 Dec20 Dec21
Return-on-Tangible-Equity
0.00 232.95 0.00

The Greenrose Holding Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.88 0.00 0.00 0.00 0.00

STU:50U vs STLY, BLMS, WECT: Return-on-Tangible-Equity Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, The Greenrose Holding Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Greenrose Holding Co Return-on-Tangible-Equity vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Greenrose Holding Co's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where The Greenrose Holding Co's Return-on-Tangible-Equity falls into.


STU:50U
22GF Score
The Greenrose Holding Co STU:50U
Return-on-Tangible-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Greenrose Holding Co Return-on-Tangible-Equity Calculation

The Greenrose Holding Co's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2021 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2021 )  (A: Dec. 2020 )(A: Dec. 2021 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2021 )  (A: Dec. 2020 )(A: Dec. 2021 )
=0/( (10.139+-102.89 )/ 2 )
=0/-46.3755
=N/A %

The Greenrose Holding Co's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2022 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Sep. 2022 )  (Q: Jun. 2022 )(Q: Sep. 2022 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Sep. 2022 )  (Q: Jun. 2022 )(Q: Sep. 2022 )
=-145.58/( (-114.684+-121.138)/ 2 )
=-145.58/-117.911
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2022) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

What does a Return-on-Tangible-Equity of 0.00% mean?
The Greenrose Holding Co (STU:50U) has a Return-on-Tangible-Equity of 0.00% as of Sep. 2022. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on The Greenrose Holding Co and its competitors.
Is The Greenrose Holding Co's Return-on-Tangible-Equity too high?
The Greenrose Holding Co's current Return-on-Tangible-Equity is 0.00%. Overall, The Greenrose Holding Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does The Greenrose Holding Co's Return-on-Tangible-Equity compare to STLY and BLMS?
The Greenrose Holding Co's Return-on-Tangible-Equity of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median Return-on-Tangible-Equity is 7.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Drug Manufacturers company?
The median Return-on-Tangible-Equity among Drug Manufacturers companies is 7.95, based on 899 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on The Greenrose Holding Co and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Equity is 7.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Greenrose Holding Co's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Greenrose Holding Co stock overvalued right now?
The Greenrose Holding Co (STU:50U) has a current Return-on-Tangible-Equity of 0.00%. The current Return-on-Tangible-Equity is 0.00%. The Greenrose Holding Co's overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For The Greenrose Holding Co (STU:50U), the current Return-on-Tangible-Equity is 0.00% as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Greenrose Holding Co Business Description

Other Exchanges GNRUQ:USA
Address 111 Broadway, Amityville, NY, USA, 11701
The Greenrose Holding Co is engaged in the manufacture and processing of cannabis in the adult-use and medical cannabis marketplace in Connecticut and Arizona.
22GF Score

Get the complete analysis for STU:50U

Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.36
Price